BIO-TECHNE ANNOUNCES STRATEGIC INVESTMENT IN SPEAR BIO

MINNEAPOLIS, July 29, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced its participation in Spear Bio's $45 million Series A funding round. Spear Bio will use the proceeds from this funding round to further accelerate product development and scale its in-house manufacturing capacity. BioTechne joined Foresite Capital, and other investors, in this funding round. "We are excited to invest in Spear Bio," said Kim Kelderman, President and Chief Executive Officer of BioTechne. "Spear Bi ...